Growth Metrics

Fulgent Genetics (FLGT) Total Liabilities (2016 - 2026)

Fulgent Genetics' Total Liabilities history spans 12 years, with the latest figure at $112.2 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 35.24% to $112.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $112.2 million, a 35.24% increase, with the full-year FY2025 number at $106.8 million, up 17.63% from a year prior.
  • Total Liabilities hit $112.2 million in Q1 2026 for Fulgent Genetics, up from $106.8 million in the prior quarter.
  • Over the last five years, Total Liabilities for FLGT hit a ceiling of $152.6 million in Q1 2022 and a floor of $83.0 million in Q1 2025.
  • Historically, Total Liabilities has averaged $107.2 million across 5 years, with a median of $103.2 million in 2024.
  • Biggest five-year swings in Total Liabilities: tumbled 39.54% in 2023 and later surged 35.24% in 2026.
  • Tracing FLGT's Total Liabilities over 5 years: stood at $116.2 million in 2022, then dropped by 12.17% to $102.0 million in 2023, then dropped by 11.01% to $90.8 million in 2024, then rose by 17.63% to $106.8 million in 2025, then grew by 5.06% to $112.2 million in 2026.
  • Business Quant data shows Total Liabilities for FLGT at $112.2 million in Q1 2026, $106.8 million in Q4 2025, and $93.8 million in Q3 2025.